Patent Assignment
Reel/Frame 058774/0052
Assignment of Assignor's Interest
Recorded: 2022-01-14
Pages: 5
Assignor
NOVARTIS PHARMA AG
Executed: 2021-12-07
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Methods for Reducing the Oxidation Level of Cysteine Residues in a Secreted Recombinantly-Expressed Protein During Cell Culture
Application:
17/557,921 →
Publication:
US 2022/0251502
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 14, 2022
From: CARINHAS, NUNO BUXO; GARCIA, DAVID; GOEBEL, MATHIAS
To: NOVARTIS PHARMA AG
Reel/Frame 058658/0520 →
Assignment of Assignor's Interest
Jan 14, 2022
From: SHULTZ, JOSEPH
To: NOVARTIS PHARMA AG
Reel/Frame 058658/0624 →
Assignment of Assignor's Interest
Jan 14, 2022
From: CUI, HUANCHUN
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 058658/0770 →
Assignment of Assignor's Interest
Feb 4, 2022
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 058891/0918 →
Assignment of Assignor's Interest
Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →